Myasthenia Gravis News and Research

RSS
Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by varying degrees of weakness of the skeletal (voluntary) muscles of the body. The hallmark of myasthenia gravis is muscle weakness that increases during periods of activity and improves after periods of rest. Muscles that control eye and eyelid movements, facial expression, chewing, talking, and swallowing are often, but not always, involved. The muscles that control breathing and neck and limb movements may also be affected. Myasthenia gravis is caused by a defect in the transmission of nerve impulses to muscles. Normally when impulses travel down the nerve, the nerve endings release a neurotransmitter substance called acetylcholine. In myasthenia gravis, antibodies produced by the body's own immune system block, alter, or destroy the receptors for acetylcholine. The first noticeable symptoms of myasthenia gravis may be weakness of the eye muscles, difficulty in swallowing, or slurred speech. Symptoms vary in type and severity. Myasthenia gravis is not directly inherited nor is it contagious.
Emory researchers discover enzyme to combat IgG-mediated disorders

Emory researchers discover enzyme to combat IgG-mediated disorders

Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis

Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Rare but real: The neurological risks associated with vaccines

Rare but real: The neurological risks associated with vaccines

Investigational drug shows promise in treating rare blood disease in fetuses

Investigational drug shows promise in treating rare blood disease in fetuses

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

World-first discovery offers potential cure for lupus

World-first discovery offers potential cure for lupus

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Association between vitamin D supplementation and fatigue

Association between vitamin D supplementation and fatigue

How do micronutrients influence neurological disorders?

How do micronutrients influence neurological disorders?

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

How do viral infections cause autoimmune diseases?

How do viral infections cause autoimmune diseases?

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Immune-mediated inflammatory diseases following COVID-19

Immune-mediated inflammatory diseases following COVID-19

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Gait analysis in animals: Treadmill versus non treadmill system

Gait analysis in animals: Treadmill versus non treadmill system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.